Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Chemotherapy At Home Services Industry By 2029?

In recent times, the market size for chemotherapy at home services has seen rapid expansion. Its growth trajectory predicts a rise from 2024’s $1.75 billion to a projected $1.94 billion in 2025, marking an impressive compound annual growth rate (CAGR) of 11.1%. The significant expansion during the historical period can be traced back to an increase in cancer cases, heightened patient preference for home-based care, limitations in hospital capacity, enhancements in home healthcare systems, and beneficial government regulations.

The market for home-based chemotherapy services is set to experience a significant surge in the coming years. The projected growth has the market reaching a size of $2.89 billion in 2029, delivering a compound annual growth rate (CAGR) of 10.4%. The expansion during the forecast period is largely owing to factors like escalating healthcare prices, an aging demographic, the proliferation of home healthcare offerings, a heightened focus on care that is tailored to the patient, the growing imperative to minimize inpatient durations, and the management of chronic diseases. The key market trends expected within this period are the inclusion of AI and machine learning, the implementation of personalized treatments, the prevalence of wearable health devices, the emergence of specialty home infusion services, and the development of collective healthcare models.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15762&type=smp

Which Industry Forces Are Driving The Chemotherapy At Home Services Market Forward?

The rise in cancer cases is likely to fuel expansion in the chemotherapy-at-home services market moving forward. Characterized by unregulated cell growth and spread, cancer has become increasingly common due to factors such as aging populations, changes in lifestyle, exposure to the environment, genetic factors, and improved detection thanks to cutting-edge diagnostic methods. Chemotherapy at-home services make it possible for cancer patients to get treatment at home, thus enhancing convenience and quality of life. For instance, data from the National Center for Biotechnology Information, a U.S. intergovernmental organization, in January 2023 show that there were 1,958,310 new cases of cancer in the U.S., and it’s projected that 609,820 cancer deaths will happen in 2023. Consequently, the rise in cancer cases is stimulating the expansion of chemotherapy at-home services.

What Is The Segment Breakdown Of The Chemotherapy At Home Services Market?

The chemotherapy at home servicesmarket covered in this report is segmented –

1) By Product:  Chemotherapy Drugs; Chemotherapy Infusion Pumps

2) By Administration: Oral; Intravenous

3) By Application: Breast Cancer; Blood Cancer; Ovarian Cancer; Colorectal Cancer

Subsegments:

1) By Chemotherapy Drugs: Oral Chemotherapy Drugs; Injectable Chemotherapy Drugs; Targeted Therapy Drugs; Chemotherapy Regimen Combinations

2) By Chemotherapy Infusion Pumps: Portable Infusion Pumps; Home Infusion Therapy Pumps; Electronic Infusion Pumps; Ambulatory Infusion Pumps

What New Opportunities Are Emerging From Trends In The Chemotherapy At Home Services Market?

Leading companies in the chemotherapy-at-home services market are pioneering innovative strategies for chemotherapy care, aiming to transform the way these services are delivered and enhance safety and convenience for patients. This refers to the practice of administering chemotherapy treatments within the comfort and privacy of a patient’s home. A case in point is Jivika Healthcare, a mobile medical service provider from India. In September 2022, they launched a program called ChemoAtHome. This program provides chemotherapy care for cancer patients. The service ensures safe and premium cancer care administered by skilled nurses under the guidance of a qualified MBBS doctor. The service constructs hospital-like environments within the patient’s home. The primary goals of ChemoAtHome are to provide convenience and reduce costs, achieving savings of between 20% to 25% on hospital bills associated with chemotherapy. The service also offers pre and post-treatment support, including video consultations with oncologists and home delivery of medications.

Which Companies Are Contributing Significantly To The Chemotherapy At Home Services Market Growth?

Major companies operating in the chemotherapy at home services market are CVS Health Corporation, Optum Inc., Fresenius Kabi, Medtronic plc, Amgen, Penn Medicine, Advocate Health Care, Medibank Private Limited, Option Care Health Inc., Amedisys Inc., Lincare Holdings Inc., Cancer Treatment Centers of America (CTCA), BioScrip Inc., Shanghai MicroPort Lifesciences Co. Ltd., Accredo Health Group Inc., LloydsPharmacy Clinical Homecare, InfuSystem Holdings Inc., Portea Medical, Amerita Inc., Jivika Healthcare, Vitalis Health and Home Care Pty Ltd., Ubiqare Health Pvt. Ltd., View Health Pty Ltd group, Sciensus Pharma Services Limited, TCP Homecare

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/chemotherapy-at-home-services-global-market-report

Which Region Is Leading Innovation In The Chemotherapy At Home Services Market?

North America was the largest region in the chemotherapy at-home services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy at home services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15762&type=smp

Browse Through More Reports Similar to the Global Chemotherapy At Home Services Market 2025, By The Business Research Company

Chemotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-peripheral-neuropathy-treatment-global-market-report

Chemotherapy Induced Anemia Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model